О. В. Занозина
Privolzhsky Research Medical University · 102 works · 2,255 citations · h-index 6
Top works
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
- Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
- Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in russia
- Genetic Polymorphism in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
- Осмотическая активность и безопасность инъекционных форм нестероидных противовоспалительных препаратов
- Свободно-радикальное окисление при сахарном диабете 2-го типа: источники образования, составляющие, патогенетические механизмы токсичности
- Коагуляционные признаки эндотелиального стресса у больных сахарным диабетом типа 2 в сочетании с артериальной гипертензией
- Oxidizing modificationof albumens in plasmaof blood of patients bydiabetes mellitus oftype 2 iin dependence ondegree ofindemnification ofcarbohydrateexchange and durationof diabetes mellitus oftype 2
- cystatin c in the diagnosis oF chronic Kidney disease in Patients with tyPe 2 diabetes MeLLitus
- Relationship of clinical efficacy of glucose lowering agents, gut microbiota, diet, and patient’s genotype in diabetes mellitus type 2
- The insulin resistance indices: necessity and opportunities in type 2 diabetes mellitus management
- Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
- Gliptins in the Incretin-Based Pharmacotherapy of Diabetes Mellitus: Opportunities and Personalization
- ВЛИЯНИЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ НА УРОВЕНЬ БЕЛКА КЛОТО
- Hypoglycemia and hyperglycemia: potential risks of polypragmasia in type 2 diabetes in hospital settings
- Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics
- КОМБИНИРОВАННАЯ ФАРМАКОТЕРАПИЯ ВАГИНИТОВ ПРИ БЕРЕМЕННОСТИ
- Opyt distantsionnogo prepodavaniya endokrinologii s ispol'zovaniem telemeditsinskikh tekhnologiy